1. A Lamin Family-Based Signature Predicts Prognosis and Immunotherapy Response in Hepatocellular Carcinoma. (10th November 2022) Authors: Yang, Yongyu; Xiao, Wang; Liu, Ruoqi; Gao, Lei; Chen, Junzhang; Kan, Heping Other Names: Bonam Srinivasa Reddy Academic Editor. Journal: Journal of immunology research Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Corrigendum to "LncRNA CDKN2B-AS1 promotes tumor growth and metastasis of human hepatocellular carcinoma by targeting let-7c-5p/NAP1L1 axis" [Cancer Lett. 2018 (Nov 28) 437:56–66]. (28th September 2022) Authors: Huang, Yuqi; Xiang, Bo; Liu, Yuanhua; Wang, Yu; Kan, Heping Journal: Cancer letters Issue: Volume 544(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Corrigendum to 'High-affinity human programmed death-1 ligand-1 variant promotes redirected T cells to kill tumor cells' [Cancer Lett. 447 (2019) 164–173]. (28th June 2019) Authors: Liang, Zhaoduan; Li, Yanyan; Tian, Ye; Zhang, Huanling; Cai, Wenxuan; Chen, Anan; Chen, Lin; Bao, Yifeng; Xiang, Bo; Kan, Heping; Li, Yi Journal: Cancer letters Issue: Volume 452(2019) Page Start: 268 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. High-affinity human programmed death-1 ligand-1 variant promotes redirected T cells to kill tumor cells. (10th April 2019) Authors: Liang, Zhaoduan; Li, Yanyan; Tian, Ye; Zhang, Huanling; Cai, Wenxuan; Chen, Anan; Chen, Lin; Bao, Yifeng; Xiang, Bo; Kan, Heping; Li, Yi Journal: Cancer letters Issue: Volume 447(2019) Page Start: 164 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Lamin B1 is a potential therapeutic target and prognostic biomarker for hepatocellular carcinoma. Issue 4 (1st April 2022) Authors: Yang, Yongyu; Gao, Lei; Chen, Junzhang; Xiao, Wang; Liu, Ruoqi; Kan, Heping Journal: Bioengineered Issue: Volume 13:Issue 4(2022) Page Start: 9211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Lamin B1 is a potential therapeutic target and prognostic biomarker for hepatocellular carcinoma. Issue 4 (1st April 2022) Authors: Yang, Yongyu; Gao, Lei; Chen, Junzhang; Xiao, Wang; Liu, Ruoqi; Kan, Heping Journal: Bioengineered Issue: Volume 13:Issue 4(2022) Page Start: 9211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. LncRNA CDKN2B-AS1 promotes tumor growth and metastasis of human hepatocellular carcinoma by targeting let-7c-5p/NAP1L1 axis. (28th November 2018) Authors: Huang, Yuqi; Xiang, Bo; Liu, Yuanhua; Wang, Yu; Kan, Heping Journal: Cancer letters Issue: Volume 437(2018) Page Start: 56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. MicroRNA‐520g induces epithelial–mesenchymal transition and promotes metastasis of hepatocellular carcinoma by targeting SMAD7. Issue 1 (29th November 2014) Authors: Kan, Heping; Guo, Wenbin; Huang, Yuqi; Liu, Dingli Journal: FEBS letters Issue: Volume 589:Issue 1(2015) Page Start: 102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Retracted: MicroRNA‐520g induces epithelial–mesenchymal transition and promotes metastasis of hepatocellular carcinoma by targeting SMAD7. Issue 1 (29th November 2014) Authors: Kan, Heping; Guo, Wenbin; Huang, Yuqi; Liu, Dingli Journal: FEBS letters Issue: Volume 589:Issue 1(2015) Page Start: 102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗